Home Page: Atherosclerosis

Time 2021-01-04 01:05:41

Web Name: Home Page: Atherosclerosis

WebSite: http://www.atherosclerosis-journal.com

ID:155756

Keywords:

Home,Page,Atherosclerosis,

Description:

Full length articleCombination of bempedoic acid, ezetimibe, and atorvastatin in patients with hypercholesterolemia: A randomized clinical trialJohn Rubino, Diane E. MacDougall, Lulu R. Sterling, Jeffrey C. Hanselman, Stephen J. NichollsDOI: https://doi.org/10.1016/j.atherosclerosis.2020.12.023Full length articleSpatial relationships among hemodynamic, anatomic, and biochemical plaque characteristics in patients with coronary artery diseaseAnubodh S. Varshney, Ahmet U. Coskun, Gerasimos Siasos, Charles C. Maynard, Zhongyue Pu, Kevin J. Croce, and othersDOI: https://doi.org/10.1016/j.atherosclerosis.2020.12.018Review articleThe multifaceted contribution of platelets in the emergence and aftermath of acute cardiovascular eventsDaniëlle M. Coenen, Alexandra C.A. Heinzmann, Mieke F.A. Karel, Judith M.E.M. Cosemans, Rory R. KoenenDOI: https://doi.org/10.1016/j.atherosclerosis.2020.12.017Open AccessEditorial“Plaque erosion” or the danger of eerily quiet appearanceGiuseppina Caligiuri, Ziad MallatDOI: https://doi.org/10.1016/j.atherosclerosis.2020.12.022Review articleNew cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?Dan Atar, J. Wouter Jukema, Bart Molemans, Pam R. Taub, Shinya Goto, François Mach, and othersDOI: https://doi.org/10.1016/j.atherosclerosis.2020.12.013Open Access The ketogenic diet: Pros and consBlair O'Neill, Paolo RaggiDOI: https://doi.org/10.1016/j.atherosclerosis.2019.11.021Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventionsPaolo Raggi, Jacques Genest, Jon T. Giles, Katey J. Rayner, Girish Dwivedi, Robert S. Beanlands, and othersDOI: https://doi.org/10.1016/j.atherosclerosis.2018.07.014Endothelial dysfunction in COVID-19: Current findings and therapeutic implicationsMatthias P. Nägele, Bernhard Haubner, Felix C. Tanner, Frank Ruschitzka, Andreas J. FlammerDOI: https://doi.org/10.1016/j.atherosclerosis.2020.10.014Open AccessNew cardiovascular prevention guidelines: How to optimally manage dyslipidaemia and cardiovascular risk in 2021 in patients needing secondary prevention?Dan Atar, J. Wouter Jukema, Bart Molemans, Pam R. Taub, Shinya Goto, François Mach, and othersDOI: https://doi.org/10.1016/j.atherosclerosis.2020.12.013Open AccessManaging hyperlipidaemia in patients with COVID-19 and during its pandemic: An expert panel position statement from HEART UKZohaib Iqbal, Jan Hoong Ho, Safwaan Adam, Michael France, Akheel Syed, Dermot Neely, and othersDOI: https://doi.org/10.1016/j.atherosclerosis.2020.09.008 Access this journal on ScienceDirect Visit ScienceDirect to see if you have access via your institution.Results of long-awaited trial on LDL in atherosclerosis Read moreGiorgio L. Colombo, Enrico Agabiti-Rosei, Alberto Margonato, Claudio Mencacci, Carlo Maurizio Montecucco, Roberto Trevisan, Alberico L. CatapanoFREE ACCESS - Volume 26, April 2017Lipid Management in Patients with High Cardiovascular Risk: Practical PerspectivesAtherosclerosis brings together, from all sources, papers concerned with investigation on atherosclerosis, its risk factors and clinical manifestations. Atherosclerosis covers basic and translational, clinical and population research approaches to arterial and vascular biology and disease, as well as their risk factors including: disturbances of lipid and lipoprotein metabolism, diabetes and hypertension, thrombosis, and inflammation. The editors are interested in original or review papers dealing with the pathogenesis, environmental, genetic and epigenetic basis, diagnosis or treatment of atherosclerosis and related diseases as well as their risk factors. More

TAGS:Home Page Atherosclerosis 

<<< Thank you for your visit >>>

Hot Websites